TABLE 4.
QC bin | QC bin description | % genome uncovered (<10×) | Average coverage | Other observations | Submit to NCBI | Tag for SRA attribute: “quality_control_ determination” | Included in FDA dashboard |
---|---|---|---|---|---|---|---|
A | No QC issues evident | <5% | >1,000× | >50% reads are SARS-CoV-2 | Yes | No quality control issues identified | Yes |
B | Some QC issues, but variant calling likely OK | 6%–40% | 100×–1,000× | Yes | Minor quality control issues identified | Yes | |
C | Insufficient data for confidence in variant calling | 40%–95% | 10×–100× | Low fraction of lineage-specific mutations, (C-WAP reports) | Yes | Sequence flagged for potential quality control issues | No |
F | Significant QC and/or study design issues | >95% | <10× | <5% reads SARS-Cov-2, suspected contamination (SNR low), low sequence quality, etc. | No | Sequence flagged for significant quality control issues | No |
Four QC categories, or bins, were established based on thresholds set for various QC metrics. Sequence tags were developed to communicate these categories directly on the sequence file in an attribute called “quality_control_determination.” Only data with QC tagged in the A or B bin was visualized on the public FDA variant analysis dashboard.